A detailed history of Pnc Financial Services Group, Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 5,385 shares of AXSM stock, worth $431,930. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,385
Previous 5,334 0.96%
Holding current value
$431,930
Previous $424,000 1.18%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$69.39 - $97.64 $3,538 - $4,979
51 Added 0.96%
5,385 $429,000
Q4 2023

Feb 09, 2024

SELL
$57.42 - $83.61 $976 - $1,421
-17 Reduced 0.32%
5,334 $424,000
Q3 2023

Nov 13, 2023

SELL
$69.25 - $82.21 $12,188 - $14,468
-176 Reduced 3.18%
5,351 $373,000
Q2 2023

Aug 11, 2023

BUY
$58.41 - $90.35 $7,885 - $12,197
135 Added 2.5%
5,527 $397,000
Q1 2023

May 15, 2023

SELL
$58.39 - $75.0 $6,014 - $7,725
-103 Reduced 1.87%
5,392 $332,000
Q4 2022

Feb 10, 2023

SELL
$39.94 - $79.72 $4,193 - $8,370
-105 Reduced 1.88%
5,495 $423,000
Q3 2022

Nov 10, 2022

SELL
$36.06 - $69.85 $565,673 - $1.1 Million
-15,687 Reduced 73.69%
5,600 $249,000
Q2 2022

Aug 12, 2022

BUY
$21.74 - $46.75 $760 - $1,636
35 Added 0.16%
21,287 $815,000
Q1 2022

May 12, 2022

SELL
$23.7 - $41.39 $23 - $41
-1 Reduced -0.0%
21,252 $879,000
Q4 2021

Feb 11, 2022

SELL
$30.7 - $43.36 $1,289 - $1,821
-42 Reduced 0.2%
21,253 $802,000
Q3 2021

Nov 05, 2021

BUY
$19.91 - $68.26 $696 - $2,389
35 Added 0.16%
21,295 $701,000
Q2 2021

Aug 06, 2021

BUY
$50.63 - $73.5 $1,620 - $2,352
32 Added 0.15%
21,260 $1.43 Million
Q1 2021

May 07, 2021

BUY
$55.91 - $81.44 $27,675 - $40,312
495 Added 2.39%
21,228 $1.2 Million
Q2 2020

Aug 07, 2020

BUY
$49.87 - $98.69 $984,084 - $1.95 Million
19,733 Added 1973.3%
20,733 $1.71 Million
Q4 2019

Feb 07, 2020

BUY
$16.71 - $106.24 $16,710 - $106,240
1,000 New
1,000 $103,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.44B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.